Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma

Clinical Cancer Research

Volumn 19, Issue 1, 2013, Pages 42-49

  Liu, Nick W ^a   Sanford, Thomas ^a   Srinivasan, Ramaprasad ^a   Liu, Jack L ^a   Khurana, Kiranpreet ^a   Aprelikova, Olga ^a   Valero, Vladimir ^a   Bechert, Charles ^a   Worrell, Robert ^a   Pinto, Peter A ^a   Yang, Youfeng ^a   Merino, Maria ^a   Linehan, W Marston ^a   Bratslavsky, Gennady ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIA; KIDNEY CARCINOMA; MICROARRAY ANALYSIS; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RNA DEGRADATION; STORAGE TEMPERATURE; TISSUE PREPARATION; TISSUE PRESERVATION; TISSUE PROCUREMENT;

ADULT; AGED; CARCINOMA, RENAL CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISCHEMIA; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 84871945956     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-2606     Document Type: Article

References (34)

1. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999-2009.
2. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, et al. Gene-expression pro files predict survival of patients with lung adenocarcinoma. Nat Med 2002;8:816-24.
3. Shi L, Tong W, Fang H, Scherf U, Han J, Puri RK, et al. Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics 2005;6(Suppl 2):S12.
4. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006;24:1151-61.
5. Kiewe P, Gueller S, Komor M, Stroux A, Thiel E, Hofmann WK. Prediction of qualitative outcome of oligonucleotide microarray hybridization by measurement of RNA integrity using the 2100 Bioanalyzer capillary electrophoresis system. Ann Hematol 2009;88:1177-83.
6. Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 2006;27:126-39.
7. Zhao Y, Simon R. BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource. Cancer Inform 2008;6:9-15.
8. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
9. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2007;3:11-7.
10. TaqMan Gene Expression Assay Search. 2012 [cited 2012 Dec 11]. Available from: https://bioinfo.appliedbiosystems.com/genomedatabase/gene-expression.html.
11. Pfaffl M. Relative quantification. In:Dorak T, editor. Real-time PCR. La Jolla, CA: International University Line; 2006. p. 63-82.
12. Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, et al. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. Biotechniques 2004;36:1030-7.
13. Lin DW, Coleman IM, Hawley S, Huang CY, Dumpit R, Gifford D, et al. Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. J Clin Oncol 2006;24:3763-70.
14. De Cecco L, Musella V, Veneroni S, Cappelletti V, Bongarzone I, Callari M, et al. Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer 2009;9:409.
15. Micke P, Ohshima M, Tahmasebpoor S, Ren ZP, Ostman A, Ponten F, et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest 2006;86:202-11.
16. Fajardy I, Moitrot E, Vambergue A, Vandersippe-Millot M, Deruelle P, Rousseaux J. Time course analysis of RNA stability in human placenta. BMC Mol Biol 2009;10:21.
17. Jewell SD, Srinivasan M, McCart LM, Williams N, Grizzle WH, LiVolsi V, et al. Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. Am J Clin Pathol 2002;118:733-41.
18. Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera GV, et al. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J Natl Cancer Inst 2011;103:1871-83.
19. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 2002;161:1743-8.
20. Nogueira M, Kim HL. Molecular markers for predicting prognosis of renal cell carcinoma. Urol Oncol 2008;26:113-24.
21. Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 2004;10:5464-71.
22. Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, Ljungberg B. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clin Cancer Res 2005;11:1129-35.
23. Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006;50:1272-7.
24. Rioux-Leclercq N, Epstein JI, Bansard JY, Turlin B, Patard JJ, Manunta A, et al. Clinical signifi cance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 2001;32:1209-15.
25. Clifford SC, Czapla K, Richards FM, O'Donoghue DJ, Maher ER. Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genes. Br J Cancer 1998;77:1420-8.
26. Vamvakas S, Bittner D, Koster U. Enhanced expression of the proto-oncogenes c-myc and c-fos in normal and malignant renal growth. Toxicol Lett 1993;67:161-72.
27. Canoz O, Belenli O, Patiroglu TE. General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors. Pathol Oncol Res 2002;8:262-9.
28. Elpek GO, Karaveli S, Simsek T, Keles N, Aksoy NH. Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries. APMIS 2003;111:523-30.
29. Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S, Muller W. Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma. Ann Thorac Surg 2002;74:222-6.
30. Yang Y, Niu ZB, Hou Y, Wang CL. The expression of HSP70 and HSP90alpha in children with Wilms tumor. J Pediatr Surg 2006;41:1062-6.
31. Linehan WM, Zbar B, Klausner RD. Renal cell carcinoma. In:Scriver CR, Beaudet A, Sly W, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001. p. 907-29.
32. van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA, Schouten LJ, Gorissen HJ, Schalken JA, et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. BMC Cancer 2005;5:57.
33. Bratslavsky G, Sudarshan S, Neckers L, Linehan WM. Pseudohypoxic pathways in renal cell carcinoma. Clin Cancer Res 2007;13:4667-71.
34. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, et al. Molecular diagnosis and therapy of kidney cancer. Annu Rev Med 2010;61:329-43.